EGLN1 and polycythemia: The central role of this pathway in regulating erythropoiesis was further underscored by the identification of patients with erythrocytosis that have mutations in PHD2[23] and HIF2α[24], [25], [26] and the demonstration that Chuvash Polycythemia was caused by mutations in VHL[27], [28].